Clinical Trial Update: Red-fleshed Apple as a Novel Anthocyanin-biofortified Food to Improve Cardiometabolic Risk Factors. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring red-fleshed apple as an anthocyanin-biofortified food to improve cardiometabolic risk factors in individuals with high LDL-chol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiometabolic Risk Factors
• High Ldl-cholesterol Levels
• Hyperlipidemia

Drugs mentioned

• Red-fleshed apple (anthocyanin-biofortified)

Snippet

Sponsor: University Rovira i Virgili | Conditions: High LDL-cholesterol Levels | Phase 2 | Status: UNKNOWN